30th Nov 2021 08:27
Judges Scientific plc
Director/PDMR Shareholding
The Company has today issued 1,775 new ordinary shares of 5p each in the Company ("Ordinary Shares") pursuant to the exercise of options at a price of 1690 pence under the Company's Approved Share Option Scheme. The new Ordinary Shares are being issued under the Company's current blocklisting.
The options were exercised by Ralph Cohen, Non-Executive Director.
As a result of the exercise Ralph Cohen's resulting interest in the Company has increased by 1,775 shares to 66,116 Ordinary Shares representing 1.05% per cent. of the issued Ordinary share capital. He holds no further options under the Company's Share Option Schemes.
Following the allotment of these shares, the enlarged issued Ordinary share capital will be 6,318,415 Ordinary Shares.
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||||||||
a)
| Name
| Ralph Cohen | |||||||
2
| Reason for the notification
| ||||||||
a)
| Position/status
| Non-Executive Director | |||||||
b)
| Initial notification /Amendment
| Initial notification | |||||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| ||||||||
a)
| Name
| Judges Scientific plc | |||||||
b)
| LEI
| 2138004EXWWPTW1JOL31 | |||||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| ||||||||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares in Judges Scientific plc
GB0032398678
| |||||||
b)
| Nature of the transaction
| Exercise of options under the rules of the 2005 Approved Share Option Scheme | |||||||
c)
| Price(s) and volume(s)
|
| |||||||
d)
| Aggregated information
- Aggregated volume
- Price
| N/A (single transaction) | |||||||
e)
| Date of the transaction
| 29/11/21 | |||||||
f) | Place of transaction | Outside of a trading venue | |||||||
Judges Scientific |
|
|
| ||||||
David Cicurel, CEO Brad Ormsby, Group FD | Tel: +44 (0) 20 3829 6970 |
|
| ||||||
Shore Capital (Nominated Adviser & Broker) |
|
| |||||||
Stephane Auton Iain Sexton | Tel: +44 (0) 20 7408 4090 |
| |||||||
Liberum (Joint Broker) Bidhi Bhoma Euan Brown William Hall
Media enquiries: Alma PR (Financial Public Relations) |
Tel : +44 (0) 20 3100 2222
|
| |||||||
Sam Modlin Justine James Joe Pederzolli | Tel: +44 (0) 20 3405 0205 |
| |||||||
Related Shares:
Judges Scientific